BioSpace News Archive

Proceeds to Support Ongoing Phase 2 Clinical Trials of Immuno-oncology Therapeutic APX005M and the Discovery and Development of a Pipeline of Novel Therapies

Soligenix, Inc. announced its recent accomplishments and financial results for the second quarter ended June 30, 2018.

Second Quarter 2018 Highlights

Paper identifies chief cloud security risks, how they fit in a greater security analysis

MedEquities Realty Trust, Inc. announced its consolidated financial results for the quarter ended June 30, 2018 and other recent developments.

Acquisition to Bolster Company’s Venous Therapies Portfolio within Peripheral Interventions Division

INSYS Therapeutics, Inc. announced today that it has reached an agreement in principle with the Department of Justice (DOJ) to settle the DOJ’s civil and criminal investigation into inappropriate sales and commercial practices by some former company employees. This agreement in principle is subject to the negotiation of final settlement documents with the government.

The open label, prospective, single arm, multi-center study will evaluate the safety, performance, accuracy and usability of XVS during spine fusion procedures involving pedicle screw placement.

Due to the immense popularity of CBD, the National Day Calendar has officially declared today, August 8th, National CBD Day.

Verdeca’s HB4® soybean trait to help growers overcome challenging climate conditions